Efficacy and safety of nebulized glycopyrrolate for administration using a high efficiency nebulizer in patients with chronic obstructive pulmonary disease-Reference-Cited by-同舟云学术

Efficacy and safety of nebulized glycopyrrolate for administration using a high efficiency nebulizer in patients with chronic obstructive pulmonary disease

Published:2015-02-20 Issue:3 Volume:79 Page:492-500
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Leaker Brian R.¹,Barnes Peter J.²,Jones C. Richard¹,Tutuncu Ahmet³,Singh Dave⁴

Affiliation:

1. Respiratory Clinical Trials Ltd; London UK

2. National Heart & Lung Institute, Imperial College; London UK

3. Elevation Pharmaceuticals Inc.; San Diego CA USA

4. Medicines Evaluation Unit; University of Manchester; University Hospital of South Manchester Foundation Trust; Manchester UK

Funder

Elevation Pharmaceuticals Inc (now incorporated with Sunovion Pharmaceuticals Inc)

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bcp.12517/fullpdf

Reference43 articles.

1. Anticholinergic agents in COPD;Gross;Chest,1987

2. The role of anticholinergics in chronic obstructive pulmonary disease;Barnes;Am J Med,2004

3. Expression of muscarinic receptors by human macrophages;Koarai;Eur Respir J,2012

4. Pharmacological characterization of the muscarinic receptor antagonist, glycopyrrolate, in human and guinea-pig airways;Haddad;Br J Pharmacol,1999

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Indian Guidelines on Nebulization Therapy;Indian Journal of Tuberculosis;2022

2. An ultrasensitive LC–MS/MS method and application to clinical dose-range finding for glycopyrrolate via an e-Nebulizer;Bioanalysis;2021-06

3. The TRIFLOW study: a randomised, cross-over study evaluating the effects of extrafine beclometasone/formoterol/glycopyrronium on gas trapping in COPD;Respiratory Research;2020-12

4. In Vitro Effect of Different Airflow Rates on the Aerosol Properties of Nebulized Glycopyrrolate in the eFlow® Closed System and Tiotropium Delivered in the HandiHaler®;Pulmonary Therapy;2020-08-18

5. Validation of a sensitive and specific LC–MS/MS method and application to evaluate the systemic exposure and bioavailability of glycopyrrolate via different drug delivery approaches/devices;Biomedical Chromatography;2020-06-16